Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
J van Ingen, MJ Boeree, D van Soolingen… - Drug Resistance …, 2012 - Elsevier
Nontuberculous mycobacteria (NTM) are increasingly recognized as causative agents of
opportunistic infections in humans. For most NTM infections the therapy of choice is drug …
opportunistic infections in humans. For most NTM infections the therapy of choice is drug …
Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?
Introduction: One-third of the world's population is infected with Mycobacterium tuberculosis
(M. tb.). Latent tuberculosis infection (LTBI) can progress to tuberculosis disease, the leading …
(M. tb.). Latent tuberculosis infection (LTBI) can progress to tuberculosis disease, the leading …
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 …
Background Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans
infection that damages the skin and subcutis. It is most prevalent in western and central …
infection that damages the skin and subcutis. It is most prevalent in western and central …
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
J van Ingen, EF Egelund, A Levin… - American journal of …, 2012 - atsjournals.org
Rationale: Currently recommended multidrug treatment regimens for Mycobacterium avium
complex (MAC) lung disease yield limited cure rates. This results, in part, from incomplete …
complex (MAC) lung disease yield limited cure rates. This results, in part, from incomplete …
Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS
Introduction Rifampicin (RIF) and clarithromycin (CLR) are common drugs for the treatment
of infections like Mycobacterium tuberculosis and Mycobacterium ulcerans. Treatment for …
of infections like Mycobacterium tuberculosis and Mycobacterium ulcerans. Treatment for …
Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation
KA Al-Anazi, AM Al-Jasser, WK Al-Anazi - Frontiers in oncology, 2014 - frontiersin.org
Non-tuberculous mycobacteria (NTM) are acid-fast bacteria that are ubiquitous in the
environment and can colonize soil, dust particles, water sources, and food supplies. They …
environment and can colonize soil, dust particles, water sources, and food supplies. They …
Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and beta-lactams
Like any other drug, antimicrobial drugs are prone to pharmacokinetic drug interactions.
These drug interactions are a major concern in clinical practice as they may have an effect …
These drug interactions are a major concern in clinical practice as they may have an effect …
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
RR Yotsu, M Richardson, N Ishii - Cochrane Database of …, 2018 - cochranelibrary.com
Background Buruli ulcer is a necrotizing cutaneous infection caused by infection with
Mycobacterium ulcerans bacteria that occurs mainly in tropical and subtropical regions. The …
Mycobacterium ulcerans bacteria that occurs mainly in tropical and subtropical regions. The …
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of …
Buruli ulcer, an ulcerating skin disease caused by Mycobacterium ulcerans infection, is
common in tropical areas of western Africa. We determined the clinical and microbiological …
common in tropical areas of western Africa. We determined the clinical and microbiological …
Lack of clinical pharmacokinetic studies to optimize the treatment of neglected tropical diseases: a systematic review
L Verrest, TPC Dorlo - Clinical pharmacokinetics, 2017 - Springer
Abstract Introduction Neglected tropical diseases (NTDs) affect more than one billion
people, mainly living in develo** countries. For most of these NTDs, treatment is …
people, mainly living in develo** countries. For most of these NTDs, treatment is …